Zhi Liu

机构：Central South University, Guiyang Medical University, Tianjin University, Chinese PLA General Hospital, Tianjin Third Central Hospital, National Clinical Research Center for Digestive Diseases, Tianjin Infectious Diseases Hospital, Affiliated Hospital of Guizhou Medical University, Cell Technology (China), Tianjin Fire Research Institute, Xiangya Hospital Central South University, Tianjin Medical University · ORCID：0000-0002-2247-8991

发表论文 34 篇 · 总被引 232 次 · h-index 8

代表论文

• Engineered 5-HT producing gut probiotic improves gastrointestinal motility and behavior disorder (2022 · Frontiers in Cellular and Infection Microbiology · 被引 35)
• Characteristics of Laryngopharyngeal Reflux in Patients of Different Genders and Ages (2022 · Journal of Voice · 被引 14)
• Comparison of Reflux Symptom Score versus Reflux Symptom Index in screening laryngopharyngeal reflux (2022 · The Laryngoscope · 被引 13)
• Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts (2023 · Frontiers in Pharmacology · 被引 10)
• Robust pyroptosis risk score guides the treatment options and predicts the prognosis of bladder carcinoma (2022 · Frontiers in Immunology · 被引 10)
• Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48 (2025 · Journal for ImmunoTherapy of Cancer · 被引 9)